Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|January 22, 2025
Intra-Abdominal Hypertension and Its Prognostic Impact on Mortality in Cirrhotic Patients with Ascites: The Role of ParacentesisUmmu Mutlu, Sezen Genc Ulucecen, Raim Iliaz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2008
Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in TurkeyBinnur Pinarbasi, Derya Onel, Fulya Cosan, et al.
Acta Gastro-Enterologica Belgica|July 11, 2007
Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapyFiliz Akyuz, Sabahattin Kaymakoglu, Kadir Demir, et al.
Annals of Hepatology|September 13, 2020
The effect of liver test abnormalities on the prognosis of COVID-19Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, et al.
Scientific Reports|July 2, 2025
Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn's diseaseAdnan Ozkahraman, Yusuf Kayar, Ramazan Dertli, et al.
Pathology, Research and Practice|October 23, 2024
IDO1-mediated catabolism of tryptophan in gastric tumors: Its potential role in the axis of histopathology, differentiation and metastasisCem Horozoglu, Mehmet Tolgahan Hakan, Dilara Sonmez, et al.
Hepato-Gastroenterology|July 13, 2004
Terlipressin and albumin combination treatment in hepatorenal syndromeAhmet Danalioglu, Yilmaz Cakaloglu, Cetin Karaca, et al.
Journal of Clinical Gastroenterology|July 20, 2012
Association of the MEFV gene variations with inflammatory bowel disease in TurkeyFiliz Akyuz, Fatih Besisik, Duran Ustek, et al.
Microbiology and Immunology|June 6, 2022
What is the clinical impact of occult HBV infections and anti-HBc positivity in patients with chronic hepatitis C?Bulent Cakal, Bilger Cavus, Alp Atasoy, et al.
Antiviral Therapy|September 15, 2012
Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of responseCetin Karaca, Ozlem M Soyer, Bulent Baran, et al.
Pageof 9